A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1998
10/22/1998	WO1998046737A2 cDNA FOR HUMAN GDNF AND PROMOTER THEREFOR WHICH ALLOWS REGULATED AND CONSTITUTIVE EXPRESSION
10/22/1998	WO1998046728A1 Methods for increasing the efficiency of recombinant aav product
10/22/1998	WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998	WO1998046638A1 A novel th2-specific gene
10/22/1998	WO1998046274A2 Cationic polymers for nucleic acid transfection
10/22/1998	WO1998046273A2 Delivery system for gene therapy to the brain
10/22/1998	WO1998046271A1 Process for infecting eukaryotic cells with a bacterial virus
10/22/1998	WO1998046262A1 Anti-influenza compositions supplemented with neuraminidase
10/22/1998	WO1998046258A2 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
10/22/1998	WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998	WO1998046250A1 Peptide antiestrogen compositions and methods for treating breast cancer
10/22/1998	WO1998046242A1 Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells
10/22/1998	WO1998046208A1 Hair follicle dna delivery system
10/22/1998	WO1998046083A1 Use of lentiviral vectors for antigen presentation in dendritic cells
10/22/1998	WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system
10/22/1998	WO1998030685A3 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
10/22/1998	WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998	DE19716098A1 Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden Fibroblasts with a foreign gene containing composition for the treatment of wounds
10/22/1998	CA2706609A1 Osteoprotegerin binding proteins and receptors
10/22/1998	CA2287518A1 A novel th2-specific gene
10/22/1998	CA2287472A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression
10/22/1998	CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998	CA2287076A1 Novel transgene expression system for increased persistence
10/22/1998	CA2286877A1 Peptide antiestrogen compositions and methods for treating breast cancer
10/22/1998	CA2286819A1 Use of lentiviral vectors for antigen presentation in dendritic cells
10/22/1998	CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998	CA2286580A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998	CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998	CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998	CA2285940A1 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
10/22/1998	CA2284832A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
10/22/1998	CA2284127A1 Flt3 ligand chimeric proteins
10/22/1998	CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2229428A1 3-dehydroquinate synthase (arob)
10/21/1998	EP0872552A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin
10/21/1998	EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998	EP0872249A1 Gene transfer preparation
10/21/1998	EP0871757A1 Conditionally replicating viral vectors and their use
10/21/1998	EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998	EP0871755A1 Vectors for gene delivery
10/21/1998	EP0871754A1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
10/21/1998	EP0871748A2 Delivery of biologically active polypeptides
10/21/1998	EP0871747A1 Immunostimulation mediated by gene-modified dendritic cells
10/21/1998	EP0871742A2 Vectors and viruses for use in gene therapy
10/21/1998	EP0871735A1 Therapeutic and diagnostic compositions
10/21/1998	EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing
10/21/1998	EP0871729A1 Steroid receptor coactivator compositions and methods of use
10/21/1998	EP0871728A2 Targets for breast cancer diagnosis and treatment
10/21/1998	EP0871725A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
10/21/1998	EP0871723A1 Somatic gene therapy to cells associated with fluid spaces
10/21/1998	EP0871713A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis
10/21/1998	EP0871711A1 Compositions and methods for site-directed integration into dna
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871667A1 G-protein coupled receptor
10/21/1998	EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998	EP0871647A1 Oligomers which inhibit expression of collagen genes
10/21/1998	EP0871645A1 Modulators of the function of fas/apo1 receptors
10/21/1998	EP0871644A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods
10/21/1998	EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions
10/21/1998	EP0871495A1 Redirection of cellular immunity by receptor chimeras
10/21/1998	EP0871494A1 Compositions and methods for treating tumor cells
10/21/1998	EP0871493A1 Smooth muscle cell-derived migration factor
10/21/1998	EP0871491A2 Polymers
10/21/1998	EP0871483A1 Helper virus-free aav production
10/21/1998	EP0871463A1 Regulation of eating behavior
10/21/1998	EP0871459A1 Vector and method of use for nucleic acid delivery to non-dividing cells
10/21/1998	EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998	EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
10/21/1998	EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
10/21/1998	EP0738327B1 Host-vector system for use in gene therapy
10/21/1998	EP0735899A4 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
10/21/1998	EP0729474A4 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
10/20/1998	US5825524 Transverse electric mode electro-optic cell for a modulator and process for producing such a cell
10/20/1998	US5824840 Diabetes-inducing transgenic mouse
10/20/1998	US5824839 Delivery of gene products via mesangial cells
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824550 Voltage-gated calcium channel and antisense oligonucleotides thereto
10/20/1998	US5824544 Adenovirus vectors for gene therapy
10/20/1998	US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery
10/20/1998	US5824504 Polynucleotides
10/20/1998	US5824501 Encoding specified amino acid sequence and vector comprising it; culturing isolated cell transfored with vector, recovering recombitant protein; treatment and prevention of boom's syndrome
10/20/1998	US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998	US5824490 Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/18/1998	CA2203083A1 Gene and cdna involved in alzheimer's disease
10/18/1998	CA2203068A1 Chromosome 1p gene and gene products related to alzheimer's disease
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045463A1 Composition for gene introduction into cell
10/15/1998	WO1998045462A1 Recombinant vectors derived from adeno-associated virus suitable for gene therapy
10/15/1998	WO1998045444A1 Vaccines with enhanced intracellular processing
10/15/1998	WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045430A1 Immune modulation by polypeptides related to cr1
10/15/1998	WO1998045428A1 Fanconi-gen ii
10/15/1998	WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045322A2 Diagnosis method and reagents

1 ... 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 ... 870